Recursion Pharmaceuticals... (RXRX)
NASDAQ: RXRX
· Real-Time Price · USD
5.51
-0.26 (-4.51%)
At close: Aug 18, 2025, 3:59 PM
Recursion Pharmaceuticals Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for RXRX stock have an median target of 6, with a low estimate of 5 and a high estimate of 10. The median target predicts an increase of 8.89% from the current stock price of 5.51.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 5 | 7 | 6 | 10 |
| Change | -9.26% | 27.04% | 8.89% | 81.49% |
Latest Analyst Insight Report
Needham has reaffirmed a Buy rating for Recursion ... Unlock content with Pro Subscription
Updated Jul 08, 2025
| Rating | Jan 25 | Feb 25 | Apr 25 | May 25 | Jun 25 | Jul 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 0 | 1 |
| Hold | 0 | 1 | 1 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 1 | 1 | 2 |
Financial Forecast this Year
Revenue This Year
70.81M
from 58.84M
Increased by 20.3%
Revenue Next Year
99.49M
from 70.81M
Increased by 40.5%
EPS This Year
-1.55
from -1.69
Increased by 8.3%
EPS Next Year
-1.23
from -1.55
Increased by 20.6%